Obesity-driven hyperlipidemia elevates circulating PUFAs (e.g., AA), which are incorporated into hepatocyte membranes via ACSL4/LPCAT3 (Yang et al., 2014). Here, ACSL4 is linked to obesity due to melanocortin 4 receptor deficiency.